PMA

P170039: CustomFlex Artificial Iris

FDA PMA · Artificial iris · Humanoptics AG

Key facts

PMA number P170039
Trade name CustomFlex Artificial Iris
Generic name Artificial iris
Applicant Humanoptics AG
Owner/operator HumanOptics Holding AG
Product code QBT
Approval date May 30, 2018
Establishment registration 3010531293
FEI number 3010531293

At a glance

  • 1–9 Supplements
  • Sep 4, 2020 Latest supplement decision
  • No Withdrawn
  • Yes Summary of safety and effectiveness on file
  • 10–99 UDI device identifiers (GUDID)
  • None MAUDE adverse event reports
  • None Recall events

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About PMA approvals

Premarket approval (PMA) is the FDA's most stringent review pathway, required for most Class III devices that support or sustain life or present a potentially unreasonable risk.

Source: U.S. Food and Drug Administration (FDA), Premarket Approval (PMA) database · Source date:

Browse all PMA approvals